Navigation Links
The deconstruction of Big Pharma

A few years ago, a VC friend of mine (that had worked previously at a Big Pharma company) talked repeatedly about a concept that was gathering force - the deconstruction of Big Pharma: deconstruction, in this case, meaning the casting away of parts and downsizing.

At that time, while I listened to him and agreed, I didn't recognize this movement as t......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 02/12/07


Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
4. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
5. Deltanoid Pharmaceuticals begins phase II osteoporosis study
6. First half of 2006 roundup: Big Pharma trumps biotech
7. Big Pharmas continued hunger and search for new products
8. Leading global Big Pharma companies of 2005
9. Theres more than a bit of mystery, but attracting Big Pharma is good for the state
10. Biotech flourishes in 2005 while Big Pharma is on the decline
11. Big Pharma already has a generic strategy, but needs new direction

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The deconstruction Big Pharma

(Date:11/24/2009)... , , Primary efficacy endpoint has been me...t endometrial cancer, , QUEBEC CITY, Nov. 24 ...SDAQ: AEZS ; TSX: AEZ) (the "Company"), a global ...rapy and oncology, today announced positive effica...otoxic peptide conjugate, AEZS-108 (formerly AN-15...
(Date:11/24/2009)... , DUBLIN, November 24 /PRNewswire-FirstC... global specialty biopharmaceutical company, today...pean Medicines Agency for,velaglucerase alfa, the ...t,for the treatment of Type 1 Gaucher disease. Thi...rase alfa that has been submitted, with previous,s...
(Date:11/24/2009)... , REDWOOD CITY, Calif., Nov. 24 /PRNewswire... ) today announced that Randy Scott, Genomic Healt...nnual Piper Jaffray Health Care Conference in New ...m. ET. ,, To access the live and subsequently ...vestor Relations section of Genomic Health,s websi...
(Date:11/24/2009)... Program Connects Customers wi...es Collected with DNA Genotek Products , ...09 -- DNA Genotek , a leading provider of product...and preparation, today announced its new global pa...ncements for DNA Genotek,s partner community and i...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...rence Call To Be Held Friday, November 14, 2008 at... Time, HOPKINTON, Mass., Nov. 13 Alseres,Pharma...rational and,financial results for the quarter end...tion for fiscal year 2008., (Logo: http://www.ne...e are encouraged by the progress we have made on o...
...SDA, Md., Nov. 13 Spherix Incorporated,(Nasdaq: ...months ended,September 30, 2008 of $1.7 million ($..., respectively. Research and development and marke...urlose as a treatment for Type,2 diabetes were app...ended,September 30, 2008, compared to approximatel...
...RBOR, Mich., Nov. 13 NanoBio Corporation announce...entations that detail,milestones in its clinical a...is, acne, herpes labialis and genital herpes durin...tists (AAPS) meeting November 16-20,2008 in Atlant...ng the conference:, Tuesday, November 18, 1:00 PM...
Other Biology Technology:Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 2Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 3Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 4Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 5Spherix Reports 3rd Quarter Earnings 2NanoBio to Give Four Scientific Presentations at Upcoming National Meeting of Pharmaceutical Scientists 2
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wildlife...rt revealing that the last remaining population of... due to the rising tide of poaching and habitat lo...inform Russian officials of what needs to be done ...ggest cat. , The report was release...
(Date:11/23/2009)...New research presents strong evidence that the "sy...utdoor traffic-related pollution and indoor endoto...or the other exposure alone. , Environmental h...UC) College of Medicine have shown that children e...icles and indoor endotoxin during early life are s...
(Date:11/23/2009)...lif. -- More than 160 participants gathered this w... FUTURES INITIATIVE conference. This year,s topic,... engineers, and medical researchers to explore the...nding the emerging field of synthetic biology. , ... at Princeton University and this year,s conferenc...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Psoriasis Video Contest Launched to Encourage Psoriasis Patients to Connect and Collaborate 54344 1Psoriasis Video Contest Launched to Encourage Psoriasis Patients to Connect and Collaborate 54344 2U S Women Delaying Motherhood Report Shows 54341 1U S Women Delaying Motherhood Report Shows 54341 22009 CMA Medal of Service 54338 12009 CMA Medal of Service 54338 22009 CMA Medal of Service 54338 3
...s a,paradigm in life science and drug development ...p;D companies. In many occasions I,ve,seen very pr...anned,because no money was to be made with it, eve... usual strategy to avoid this fate is to find,a dr... addition to the,"non-profitable" one. PLoS Medeci...
...l application involving the buzzword "nano" - canc... resonance imaging) : ,Accurate staging of cancer...p of patients for both prediction of prognosis and...And an essential part of this work,up is assessing...urrent,methods include surgical removal of nodes f...
...mes a,potential target for a drug seems very promi...reality. Its the case of telomerase inhibitors,to ...rtal" (able to,divide indefinitely) aspect of canc...k their function, preventing them to inhibit compl...roject? Look for something,else? Hell no! Look out...
Other Biology News:Finding Cures For Tropical Diseases: Is Open Source An Answer? 2Imaging Lymph Nodes with Nanoparticles 2GATA: a graphic alignment tool for comparative sequence analysis 2
...via cardiac puncture from 3 to 4 week old rabbits ...uged and frozen at -70C. The complement is thawed,...tored at -70C. DIRECT SALES FROM PEL-FREEZ BIOLOGI..., YOU CAN NOW BUY DIRECTLY FROM THE SOURCE! FORMER...
Dacron mesh button tether single channel infusion of rats, sterile from Instech Solomon
GIBCO Donor Calf Serum from Invitrogen
Genes VI from Promega
Biology Products: